Correlation Between NYSE Composite and Cardio Diagnostics
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Cardio Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Cardio Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Cardio Diagnostics Holdings, you can compare the effects of market volatilities on NYSE Composite and Cardio Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Cardio Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Cardio Diagnostics.
Diversification Opportunities for NYSE Composite and Cardio Diagnostics
-0.23 | Correlation Coefficient |
Very good diversification
The 3 months correlation between NYSE and Cardio is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Cardio Diagnostics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardio Diagnostics and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Cardio Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardio Diagnostics has no effect on the direction of NYSE Composite i.e., NYSE Composite and Cardio Diagnostics go up and down completely randomly.
Pair Corralation between NYSE Composite and Cardio Diagnostics
Assuming the 90 days trading horizon NYSE Composite is expected to generate 3.85 times less return on investment than Cardio Diagnostics. But when comparing it to its historical volatility, NYSE Composite is 17.34 times less risky than Cardio Diagnostics. It trades about 0.24 of its potential returns per unit of risk. Cardio Diagnostics Holdings is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 31.00 in Cardio Diagnostics Holdings on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Cardio Diagnostics Holdings or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
NYSE Composite vs. Cardio Diagnostics Holdings
Performance |
| Timeline |
NYSE Composite and Cardio Diagnostics Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Cardio Diagnostics Holdings
Pair trading matchups for Cardio Diagnostics
Pair Trading with NYSE Composite and Cardio Diagnostics
The main advantage of trading using opposite NYSE Composite and Cardio Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Cardio Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardio Diagnostics will offset losses from the drop in Cardio Diagnostics' long position.| NYSE Composite vs. Vita Coco | NYSE Composite vs. Franklin Wireless Corp | NYSE Composite vs. Ambev SA ADR | NYSE Composite vs. Toro Co |
| Cardio Diagnostics vs. Eliem Therapeutics | Cardio Diagnostics vs. Scpharmaceuticals | Cardio Diagnostics vs. Milestone Pharmaceuticals | Cardio Diagnostics vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |